Although variation in individual lifestyle and genotype are important factors in explaining individual variation in the risk of developing obesity in an obesogenic environment, there is growing evidence that developmentally plastic processes also contribute. These effects are mediated at least in part through epigenetic processes. These developmental pathways do not directly cause obesity but rather alter the risk of an individual developing obesity later in life. At least two classes of developmental pathway are involved. The mismatch pathway involves the evolved adaptive responses of the developing organism to anticipated future adverse environments, which have maladaptive consequences if the environment is mismatched to that predicted. This pathway can be cued by prenatal undernutrition or stresses that lead the organism to forecast an adverse future environment and change its developmental trajectory accordingly. As a result, individuals develop with central and peripheral changes that increase their sensitivity to an obesogenic environment. It provides a model for how obesity emerges in populations in rapid transition, but also operates in developed countries. There is growing experimental evidence that this pathway can be manipulated by, for example, postnatal leptin exposure. Secondly, maternal diabetes, maternal obesity and infant overfeeding are associated with a greater risk of later obesity. Early life offers a potential point for preventative intervention.
Introduction
Most research in obesity has focused on the interplay between individuals and their environment, considering potential genetic determinants on one hand, and lifestyle and nutritional factors on the other. Certainly the proximate cause of obesity usually lies in the individual's lifestyle, but greater consideration must be given to how varied individual risk is generated within an obesogenic environment. In this regard, our expanding knowledge of developmental processes suggest that they play a significant role in generating a greater risk of obesity and its complications in any particular environment.
At least two developmental pathways may be involved. There is growing evidence that signals originating from conditions suggesting a potentially nutritionally limited environment in early life position individuals through epigenetic processes in such a way that they are more likely to be mismatched in a later energy-rich environment and thus to be at greater risk of metabolic compromise. This mismatch pathway has played a major role in determining the limits of nutrient environment in which humans can live without compromise. It plays a major role in explaining patterns of obesity emerging in populations in rapid transition. A second set of developmental pathways exists by which fetal or infant overnutrition can affect later development in a manner that can also be manifested as obesity and disease. Such overnutrition may have its origin in maternal diabetes, maternal obesity or infant overfeeding. These are a rapidly emerging group of at-risk people.
These two classes of developmental pathway are likely to play a major role in determining individual sensitivity to an adipogenic environment, and thus in explaining the emergent patterns of metabolic compromise and obesity. Together, they are likely to account for the U-or J-shaped relationship between birth weight and later obesity or insulin resistance.
1,2 A harder issue is to quantify the relative importance of these effects, as they do not act in isolation; indeed the experimental evidence would suggest that the primary effect of the developmental phase is to alter the risk of an individual developing obesity and insulin resistance in particular energetic environments later in life. 3 As suggested in a recent evaluation in the United Kingdom, 4 early life offers a unique point for intervention to reduce the risks of pathogenic adiposity.
Developmental processes
Normal development is a balance between two classes of processFthose that constrain development toward a particular phenotype (often termed robustness or canalization, although these are not equivalent terms) and those that allow the phenotype to be varied according to environmental cues operative during early development (developmental plasticity). 5, 6 The general genetic and medical model assumes that developmental robustness lies primarily within the genome, although this view of genetic primacy can be considered narrow and misleading in that it separates genetic determinants from those of the developmental niche. 7 Developmental plasticity, on the other hand, can be envisaged as a set of mechanisms that can adjust the evolutionarily determined genetic potential of the organism to be better adapted to its environment, taking into account information from early in the life course of that particular individual. Because such plasticity has major costs, it is essentially limited to early development. Elsewhere we have reviewed the possible ways in which a developing organism can respond to environmental stimuli. 8 Some stimuli such as infections and toxins are non-physiological and disrupt the developmental programme. The consequences may be teratogenic. But with respect to this paper, our focus is on environmental cues and processes that may affect phenotypic outcomes but do not disrupt the basic developmental programme. The processes by which this occurs can in turn be considered in two classes. First, the cue may be sufficiently severe to require either a response from the mother giving her survival primacy over that of the fetus/infant, or alternatively the fetus/infant must make an immediate set of rheostatic responses 9 to improve its possibility of survival. Thus, fetal growth retardation may be a result of either placental and maternal ill-health, in which case the fetus may reduce growth to conserve limited nutrients for brain and cardiac functions essential to allow survival, or under conditions of famine the mother may have to take primacy in nutrient utilization as in evolutionary terms maternal survival is essential if fitness is to be maintained. (Fitness here is an evolutionary term used to describe the potential to pass the genetic lineage to subsequent generations.) Although there is an adaptive origin to this scenario, the offspring must cope later in life with the consequences of this tradeoff. To extend the example, to be born with severe growth retardation has obvious costs in terms of morbidity but at least the opportunity of reproductive success is not totally lost. 
Epigenetic mechanisms
It is now widely accepted that the processes of developmental plasticity act through alterations in anatomical and functional development that are mediated directly or indirectly by epigenetic processes. Epigenetics in the current context refers to those mechanisms that lead to long-term changes in gene expression through chemical modification to or alterations in the packaging of DNA such that the capacity for transcriptional regulation is altered. 14 This may involve methylation of CpG sequences in the promoter regions of the gene or altered acetylation, methylation or ubiquitination of histones. These may be interlinkedF enhanced methylation may lead to or be induced by deacetylation of histones. CpG methylation alters the structure of the DNA and changes its capacity to bind specific docking proteins, which in turn affects the capacity for transcriptional regulators to bind. If the transcriptional factor is an enhancer of DNA transcription, then methylation leads to reduced expression. This is the more common situation, but reduced binding of suppressors may also be observed. Alterations in histone chemistry lead to altered coiling of DNA around the histone core and thus to altered access of transcriptional factors. A further mechanism may involve microRNAs, which may also act to alter access of transcriptional regulators to the DNA. This is a rapidly developing area of post-genomic biology made particularly complex by methodological considerations. Further, as a promoter region may contain many CpGs, each may be subject to individual regulation, thus leading to high levels of specificity. DNA methylation is the most studied process and involves a family of DNA methyltransferases that regulate methylation and a less well-understood group of demethylases. 15 DNA methylation is involved in a variety of different forms of transcriptional regulation that are often lumped together, and it seems likely that this biochemical process has been coopted for distinct functions. Transposon silencing, parental imprinting, X-chromosome inactivation and cell differentiation involve gene silencing through epigenetic mechanisms. 16 Similarly, somatic epimutations may play a role in many cancers. 17 Although the role of epigenetics in developmental plasticity has focused largely on parental imprinting, we suspect imprinting has other critical functions and is unlikely to be regulated within the normative range of developmental environments to affect metabolic regulation later in life, although it may play a role in more disruptive situationsFfor example, imprinting disorders such as the Weidemann-Beckwith syndrome are more common in the offspring following assisted reproductive techniques. 18 But developmental plasticity operates within the normative range of developmental environments, and there is growing evidence that there is extensive and specific regulation of non-imprinted genes in such environmentally regulated plasticity. [19] [20] [21] [22] As developmental plasticity is basically an adaptive process, it seems more likely that it will be non-parentally imprinted genes that will be primarily involved in developmental pathways to obesity.
Life history
An organism's life history strategy has evolved to strike a balance between investment in growth, defense, maturation and reproduction in relationship to energetic considerations. Thus humans have evolved a strategy of long lives and few offspring; those offspring have delayed maturation and receive substantial parental investment. Compared with other mammals, humans have a high amount of white fat at birth, and it has been argued that this fat is an important energetic buffer for brain development against the risk of malnutrition following weaning. 23 Indeed, recent studies show that, in children born smaller, visceral fat is maintained despite fetal nutrient supply limitations, 24, 25 suggesting the importance of non-thermogenic metabolic capacity in infancy across our evolution.
The 'mismatch' or 'thrifty' pathway
Over the past two decades, a considerable amount of experimental and clinical evidence has emerged to show that an impaired embryonic, fetal or infant environment can lead to a greater risk of visceral obesity and metabolic compromise in later life. This phenomenon has been the focus of a growing field of research known as the 'developmental origins of health and disease'. Some of the earliest observations made were those of Van Assche and colleagues 26, 27 , who in the 1970s showed that experimentally induced fetal growth retardation in rats led to offspring with a greater risk of insulin resistance and abnormal pancreatic function. The significance of these observations was unappreciated at the time. In the 1980s, Barker and colleagues 28, 29 began a series of now classical epidemiological studies showing that impaired fetal development as reflected in reduced birth size had later cardiovascular and metabolic effects. Subsequently it was shown that those born smaller had greater body fat, less lean body mass and greater visceral adiposity as they approached old age. 30 Although the data relating birth size to metabolic outcomes was initially controversial, there are now a large number of studies relating birth size to later insulin resistance 31 and a smaller number relating birth size to adult adiposity. 32 More recently, a number of prospective cohort studies from birth or before have shown that the pattern of excess adipose gain is present in those of lower birth size from early in life. 33 This is supported by studies in detail of particular subgroups. For example, there is specific gain of visceral adipose tissue by 6 years of age in children born after intrauterine growth retardation. 34 The prospective evidence is supported by studies reporting body composition at birth as determined by magnetic resonance imaging. These show that although smaller babies have reduced subcutaneous fat with the reduction proportionate to birth size, visceral fat is preserved so that the smaller babies have relative visceral adiposity. 24, 25 Given the labile function of visceral fat, 35 this provides a plausible route to later metabolic compromise. Importantly, the epidemiological studies revealed that later clinical outcomes such as cardiovascular disease are not related to a low birth size per se, but rather that there is a continuous relationship between birth size and later disease risk, which continues across the entire birth size range although at the highest birth sizes the risk may again rise as within this group lies the offspring of the gestational diabetic mother. 2, 36, 37 Thus, birth size is not envisaged as the causative factor for later disease susceptibility, but is rather seen as a surrogate for maternal, environmental and placental factors that impair fetal nutritionFthat is the delivery of nutrients across the placenta to the fetus. A variety of factors can impair fetal nutrition either directly or indirectly. 38, 39 Besides the focus on the extremes caused by overt maternal and placental disease, there is a growing consideration of the non-pathophysiological factors that impact on fetal nutrition or fetal growth. For example, fetal growth is impaired in those who are born to smaller mothers, to primigravida, or to very young mothers; this is sometimes termed 'maternal constraint'. Thus, first-born children may be at particular risk 40 and demographic changes that have led to a decrease in family size mean that the proportion of first-born children in the population has increased. Similarly, there is evidence that variation in maternal nutrition within the usual range of intakes of Western women can affect fetal physiology, size at birth and subsequent endothelial function in childhood. [41] [42] [43] [44] There is a very large body of experimental evidence (for review, see McMillen and Robinson 45 ) relating altered fetal development to later obesity and metabolic compromise. These studies, usually performed in rodents or sheep, typically challenge fetal development by reducing overall maternal nutrition, by specifically reducing maternal protein intake or by administering glucocorticoids to the mother. The outcome is remarkably stereotypic, suggesting common underlying mechanisms: offspring develop endothelial dysfunction, a tendency to obesity, insulin resistance and disordered pancreatic function. Several points arise from such studies. First, there is an interaction between the prenatal and postnatal environmentsFsuch that the combination of a prenatal low-nutrient diet and a post-weaning high-fat diet has a far greater effect on adiposity than does a postnatal high-fat diet alone. 46 Secondly, the studies suggest that multiple components of the adipose phenotype are affected. These include central effects such as those on appetite control and food preferenceFoffspring of nutritionally impaired pregnancies have a preference for higher fat foods and are hyperphagic. 46, 47 The reduced activity in open field testing may reflect mood alterations or reduced voluntary exercise. 48 The animals have neuroendocrine alterations in the hypothalamus. 49 They are also sarcopenic, develop endothelial dysfunction, visceral, hepatic and subcutaneous obesity and have disordered expression of metabolic genes in peripheral tissues. This suggests that there is a coordinated central and peripheral response to an impaired fetal experience. The effect of nutrition on later outcomes has been shown from the periconceptional period through to weaning, 45 although it remains unclear how far the various responses are specific to different developmental windows.
The likely proximate mechanisms of this relationship are reviewed elsewhere, [50] [51] [52] [53] with much interest focusing on epigenetic processes, in part because of the growing evidence that the alterations in gene expression in metabolic pathways are in turn underpinned by upstream methylation changes in specific regulatory genes such as for the peroxisome proliferator-activated receptor (PPAR)-a and the glucocorticoid receptor, which are central to control of carbohydrate and lipid metabolism. 19, 20 These are not parentally imprinted genes, supporting a role for nonimprinted epigenetic change in the regulation of developmental plasticity.
Several studies have now shown in the rodent that administration of leptin in the neonatal period, either directly or via the mother, prevents the development of the metabolic phenotype and in particular the development of adiposity. 54, 55 This in turn is associated with reversal of the changes in metabolic gene expression and methylation of these genes in liver tissue when examined as adults. 20 There are gender differences, 55, 56 either reflecting the different role of body mass in reproductive success across the genders or different timings of maturation between species. The mode of action of leptin is speculative. It may act directly or indirectly on those epigenetic processes regulating metabolic canalization. 20 It may be acting by effects on neonatal food intake, but this seems unlikely given that large changes in infant food intake in this model cause only minor modification of the adult phenotype. There is evidence that leptin has effects on the maturation of hypothalamic circuits controlling food intake, 57 and a key question is whether there is a critical period that is accessible in other species, such as the human, that are more mature at birth. Barker and Hales 58 proposed that the relationship between low birth weight and later disease susceptibility was a result of the fetus making adaptations such as insulin resistance to survive maternally driven undernutrition, leaving the organism with a 'thrifty phenotype,' which then had to cope with the subsequent richer postnatal environment. This explanation is certainly compatible with the concept that immediate adaptive responses allow a fetus to survive a threatening circumstance although with a tradeoff against later problems. However, it is a less satisfactory explanation for variation across the normative range and in any event insulin resistance does not develop until well after birth. 59 We 3 and Bateson 60 independently proposed an extension of this line of argument, suggesting that these relationships are responses to variation within the anticipated range of early developmental environments and involve the physiological processes of developmental plasticity rather than the pathological processes of developmental disruption. In particular, both of us proposed an anticipatory model based on the considerable comparative evidence that organisms in early development may make adaptive responses which are of no advantage at the time they are made but are able to better match the organism to the later predicted environment. These have been termed 'predictive adaptive responses'. 11 If the developing organism anticipates a nutritionally compromised future environment, then the appropriate response is to induce a suite of coordinated responses that will maximize reproductive fitness in that environment. These would include a tendency to prefer a high-fat diet, hyperphagia, less investment in muscle mass and a tendency to visceral adipose stores when excess energy was available. 50, 61 These adaptations would be of no adverse consequence in a nutritionally limited environment, as was likely to have been the case for humans in pre-agricultural history, but are likely to lead to mismatch in modern environments. As the likelihood of high-energy environments grows in modern times, the risk of mismatch and thus obesity grows.
Developmental and epigenetic pathways to obesity PD Gluckman and MA Hanson
The action of leptin to reverse the development of adiposity adds weight to this interpretation. 62 Leptin may be acting to send a signal of high adipose reserve (that is, a high nutritional environment) when in fact the animals have been in a low nutritional environment, and thus may be resetting the developmental trajectory within the window of plasticity by switching the prediction from that of a low to a high-nutrient environment. Other strategies for reversal may also be possible. 63, 64 It is the mismatch between the developmental trajectory chosen in response to the early-life signals and the later adipogenic environment that creates the added risk of obesity. It is interesting to note the broad nature of the induced phenotype, including altered food preference and appetite, alterations in intermediary metabolism including insulin resistance, and sarcopenia. 46, 48 Such changes would all shift the individual toward a higher risk of obesity in an adipogenic environment. Studies of human cohorts in quite disparate populations show that from infancy there are particular patterns of body mass gain in individuals who develop diabetes or cardiovascular disease over their life course. 65, 66 Maternal constraint limits nutrient transfer and therefore imposes an upper limit on the richness of the external environment that the fetus can sense; in turn, this limits the postnatal environment with which the offspring can cope without risk of mismatch. 39 This could well explain ethnic differences in susceptibility to metabolic disease, such as the greater risk of metabolic compromise in South Asians, who have much lower birth weights, relative to Europeans of a similar body mass. 67 Provocatively there are experimental and clinical data showing that females born after impaired intrauterine environments tend to have earlier puberty. 68 There are also data showing that children who gain weight faster also have earlier puberty; in both humans and rats there is a synergism between impaired early development and pre-pubertal weight gain in accelerating the age of female puberty. 69, 70 One interpretation might be that the primary predictive adaptive response to an impaired early environment is to accelerate maturation in an attempt to preserve fitness. However, it can also be interpreted that as pregnancy in a young female without adequate energetic stores is likely to compromise both maternal and offspring health, accelerated maturation must be associated with increased energy stores before first conception. Thus, an evolutionary argument can be presented to suggest that the tendency to adiposity is to support reproductive fitness. There is experimental evidence for gender-specific effects 55, 56, 70 supporting such an interpretation. Less experimental and clinical data are available for males, and the preferred life-course strategy in males may depend on the species-specific mating system. In most species, enhanced male body size confers the potential for mating dominance in a transient period of the life course. Ongoing research should consider gender-specific effects. Another research challenge is to identify the prevalence of the mismatch pathway. It has been argued from epidemiological data that it is a major contributor to risk of heart disease and diabetes, 71 but there is currently no biomarker that can detect alterations in the trajectory of metabolic development. Until this existsFand it is likely to be some measure of specific epigenetic changeFthe prevalence of the mismatch pathway and its importance in susceptibility to obesity can only be estimated from the substantial clinical and experimental data. The model can explain a number of apparently puzzling features of the demography of obesity, such as the rapid appearance in populations undergoing the nutrition transition 72 and the higher incidence in first-born children. 40 A particular concern arises from observations that for cultural and socioeconomic reasons women even in developed countries may not receive optimal nutrition during pregnancy. In Japan, birth weight is falling in parallel with a reduction in maternal weight gain, in part because of an unsubstantiated belief that dietary restriction of weight gain improves pregnancy outcome. 73 Recent evidence from the United Kingdom shows that the prevalence of imprudent diet in pregnancy is very highFup to 50% of women in the lowest educational groups had a diet inappropriate to support an optimal fetal outcome. 74 This discussion has deliberately avoided use of the word 'programming'Fa term that has become widely used within the developmental origins of disease field to refer to the relationship between early life and later disease. This metaphor has serious limitations. It implies that there is a hardwired non-reversible trajectory, which is clearly not the caseFthe developmental process is continually subject to external influences, more so early in life. Our studies with early-life administration of leptin 55 show that reversibility is possible. Similarly, the focus on low birth weight in the literature and its critique is entirely misleadingFas we have discussed above, there is good evidence that extends the phenomenon across the whole of the developmental range.
The 'early-life hypernutrition' pathways
There is a second group of developmental pathways to obesity of rapidly emerging importance. These pathways reflect the effects of hypernutrition during fetal or early postnatal life and may be mediated by perturbations of adipogenesis and/or appetite control mechanisms, creating the conditions for the later pathophysiological effects of an obesogenic diet. Given that none of these conditions is likely to have been of significance in pre-modern times, these are essentially evolutionarily novel phenomena in which the environment may affect the pattern of development with pathological consequences by co-opting physiological processes. The fetal hypernutrition pathway is best defined in relation to the offspring of mothers who have type 2 diabetes or develop gestational diabetes, which itself reflects the insulin resistance arising from altered metabolic partitioning during pregnancy. Adipogenesis begins in mid to late gestation, and formation of adipose tissue occurs around the time of birth as existing fat cells expand and precursor cells differentiate. Insulin is adipogenic in late fetal and infant life, probably increasing both fat cell number and fat cell content, 75 and increased fetal adipogenesis is believed to underlie the macrosomia frequently observed in infants of diabetic mothers. The pathway by which maternal diabetes impacts fetal growth is believed to be that maternal hyperglycemia leads to greater transfer of glucose across the placenta, which is via a process of facilitated diffusion and is therefore partially concentration dependent. In turn, increased delivery of glucose to the fetus in late gestation leads to increased fetal insulin release and this in turn leads to greater adipogenesis. This is supported both by experiments in which fetal monkeys have been infused with insulin 76 and by clinical observations. 77 Generally, infants of gestational diabetics are macrosomic, with the degree of macrosomia partially dependent on the degree of diabetic control. Although fetal hyperinsulinemia may lead to a small increase in lean body mass, the greater effect is on fat mass, 78 and postnatal weight gain curves for such children show a faster gain of body mass relative to children of non-diabetic mothers by 4 years of age. 79 Increasing hyperglycemia in pregnancy predicts a greater risk of childhood obesity. 80 Preexisting type 2 diabetes or gestational diabetes affects 8-9% of pregnancies in the United States. 81 There is increasing concern about the role of maternal obesity independent of clinically apparent diabetes, and overweight or obesity affects nearly 50% of pregnancies in the United States. 82 Indeed, evidence is accumulating that fat mothers give birth to babies who later become fat children. For example, in one US cohort, maternal firsttrimester obesity led to a two-to threefold increase in the risk of childhood obesity in the progeny, such that 24% of children of obese mothers were themselves obese at age 4 years compared with 9% of children of normal-weight mothers. 83 Maternal weight loss by pre-pregnancy bariatric surgery prevents transmission of obesity to children compared with the offspring of mothers who did not undergo the surgery and remained obese. 84 Gestational weight gain irrespective of pre-pregnancy body mass is positively associated with obesity at 3 years. 85 Higher birth weight is linked by strong epidemiological evidence to childhood, adolescent and adult obesity, as demonstrated by the large cohort studies showing a greater prevalence of overweight in individuals born large 32 as well as more recent clinical studies showing that mothers with a higher pre-pregnant body mass index or a larger mid-upper-arm circumference during pregnancy tend to have children with greater adiposity at the age of 9 years. 86 There may be an additional cultural component 87 to such intergenerational transmission of obesityFin a UK cohort, the strength of association between parental BMI and offspring BMI at age 7.5 years was similar for both parents, 88 suggesting an effect of a shared parental environment.
Feeding an obesogenic diet to female mice from before mating through lactation leads to maternal obesity as well as hyperphagia, increased adiposity, decreased muscle mass and reduced locomotor activity in the offspring. 89 Our own data shows that this is associated with epigenetic changes in the promoters of metabolically associated genes with some changes parallel to and others distinct from those induced by maternal undernutrition (Vickers, Sloboda and Gluckman, unpublished data). It also leads to accelerated puberty, which raises some intriguing possibilities as to whether this is a life history response to a perceived healthy early environment or is a pathophysiological consequence of altered hypothalamic maturation and/or function. Although maternal gestational diabetes causes later obesity in rats, 90 an effect that can be mimicked by neonatal administration of insulin, 91 it is not clear that obese mothers have hyperinsulinemic fetuses or infants, and additional mechanisms need to be considered. There is evidence for maternal influences on fetal adipogenesis in animal models of earlylife overnutrition. 92 In sheep, increased maternal nutrition results in increased adipogenic, lipogenic and adipokine gene expression in fetal adipose tissue. 93 A further possible mechanism relates to the establishment of the set points of hypothalamic appetite control systems in the offspring. The hypothalamus, particularly the arcuate and paraventricular nuclei, integrates signals of nutrient availability to control feeding behavior via secretion of appetite-stimulating and appetite-suppressing neuropeptides. 94 These appetite control circuits are plastic in early life and can be affected by nutritional factors, although the critical windows for plasticity are dependent on the maturity at birth of the particular species. Maternal or fetal hyperglycemia, maternal overfeeding during pregnancy or postnatal overfeeding of the offspring have been shown to affect the maturation and functioning of these appetite-controlling hypothalamic networks, both in the sheep where (as in humans) the regulatory circuits are relatively mature at birth 95 and in the rat where the circuits are not fully developed until shortly before weaning. 96 The critical window for hypernutrition may extend further into postnatal life, as numerous clinical studies, summarized in systematic reviews and meta-analyses, 33, [97] [98] [99] have shown that rapid weight gain during early infancy is associated with susceptibility to obesity in adulthood. Such rapid weight gain is often associated with formula feeding, and some [100] [101] [102] but not all 103 observational studies and metaanalyses have found that breast-feeding is protective against obesity in later life. Similarly, studies that have manipulated the composition of formula feeds have shown protective effects of slower growth against later cardiovascular risk factors in adolescence. 104, 105 There are several possible mechanisms. Formula has a very different protein content and composition. 106 Formula-fed children drink higher volumes, which may entrain satiety differently. 107 Breastfed infants may have a different gut biota, and thus their biotic conversion of intestinal nutrients may be different, Developmental and epigenetic pathways to obesity PD Gluckman and MA Hanson leading to different absorption. 108 It may be that unrestricted bottle feeding after a period of relative constraint in fetal life merely exaggerates a mismatch. All these may induce short-term effects on development, which, as they are occurring through a phase of metabolic and neuronal plasticity, may later manifest in greater sensitivity to an obesogenic diet.
Final comments
These two classes of developmental pathway, broadly defined by undernutrition and hypernutrition in early life, are not mutually exclusive and may coexist. For example, women who themselves were born small are more likely to become insulin resistant in pregnancy, and thus the fetus is both constrained through the mismatch pathway and has excess adiposity secondary to maternal gestational diabetes or induced maternal obesity. 10 Further, so-called 'catch-up'
or 'compensatory' growth, accelerated growth after early nutritional restriction, may pose particular problems for later metabolic health. The deleterious effects of catch-up growth are apparent from theoretical models, 109 animal studies, 110 clinical evidence 34, 111 and epidemiological studies. 65, 66 The relative contributions of impaired prenatal growth and accelerated postnatal growth in such situations remain to be disentangled, although some experimental studies 112 have suggested that attenuation of catch-up growth after low birth weight is protective against later obesity. The key point is that developmental cues create sensitivity to later conditions, impacting on behavior (appetite, food choice and possibly activity levels) and on metabolic partitioning. The clinical and societal implications of these developmental pathways to obesity are several fold. There are several intertwined intergenerational cycles. In the nutritionally and socioeconomically poorest environments, one sees a cycle of disadvantage: a poor start to life gives rise to women who as mothers are short and undernourished and recreate the developmental niche leading to a poor start to life. But as the nutritional transition progresses, one sees the mismatch pathway emerging, and, in turn, the offspring of that pathway may grow up in very rich environments, generating a cycle of gestational diabetes and/or maternal obesity leading to obese offspring who themselves give birth to obese offspring. 113 Breaking these intergenerational cycles of obesity requires a focus on optimal nutrition through the life course.
